RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,754 | -16.3% | 2,550 | 0.0% | 0.00% | – |
Q2 2023 | $3,290 | -2.3% | 2,550 | 0.0% | 0.00% | – |
Q1 2023 | $3,366 | -12.0% | 2,550 | 0.0% | 0.00% | – |
Q4 2022 | $3,825 | +27.5% | 2,550 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 2,550 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -62.5% | 2,550 | 0.0% | 0.00% | – |
Q1 2022 | $8,000 | +14.3% | 2,550 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -22.2% | 2,550 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -18.2% | 2,550 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | +22.2% | 2,550 | 0.0% | 0.00% | – |
Q1 2021 | $9,000 | 0.0% | 2,550 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | +50.0% | 2,550 | 0.0% | 0.00% | – |
Q3 2020 | $6,000 | +20.0% | 2,550 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +25.0% | 2,550 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -20.0% | 2,550 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | 0.0% | 2,550 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | -28.6% | 2,550 | 0.0% | 0.00% | – |
Q2 2019 | $7,000 | 0.0% | 2,550 | 0.0% | 0.00% | – |
Q1 2019 | $7,000 | – | 2,550 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |